Methods: A total of 63 patients who underwent chest wall resection and reconstruction between January 2018 and December 2022 were included in the retrospective study. The patients were divided into two groups: the first group, which included 31 patients (14 males, 17 females; mean age: 44.6±16.4 years; range, 16 to 71 years) who were closed primarily, and the second group, constituting 32 patients (25 males, 7 females; mean age: 54.6±17.2 years; range, 9 to 80 years) who underwent reconstruction with plates and meshes.
Results: There was no significant difference between the two groups in terms of smoking and diabetes. Primary chest wall or metastatic tumor was determined in 33 patients; benign tumor and trauma were determined in 30 patients. The difference between the two groups in mean defect diameter (p=0.009), mean number of plates used (p<0.001), and mean hospital stay (p<0.001) was statistically significant. However, there was no significant difference in terms of complications (p=0.426).
Conclusion: Wide chest wall resection and reconstruction is a safe and feasible surgical procedure when compared with primary closure.
The optimum material for rigid chest wall reconstruction should be easily shaped and applied, provide enough rigidity while avoiding paradoxical breathing, allow tissue growth, have good tissue compatibility, and not cause a foreign body reaction.[1,4,5] Synthetic materials used in rigid reconstruction include double mesh methyl methacrylate, titanium plates, titanium mesh, and polypropylene-polyester denim prostheses. Chest wall reconstruction has evolved into a field that can be both simple and complex, where patient-specific aspects are prominent and various procedures are applied concurrently with technological advancements.[5] In this study, we aimed to offer our experiences in wide chest wall resection and reconstruction compared with other primary closures of the chest wall defect.
The patients who underwent chest wall reconstruction at our institution were grouped into two categories: primary closure of the defect without the use of any plate, mesh, or muscle flap (n=31; 14 males, 17 females; mean age: 44.6±16.4 years; range, 16 to 71 years) and (chest wall reconstruction with a plate or mesh, with or without a muscle flap (n=32; 25 males, 7 females; mean age: 54.6±17.2 years; range, 9 to 80 years). In the second group, chest wall stabilization with a titanium plate for traumatic patients was included. Occasionally, titanium plate reconstruction was used following the resection of two ribs if there was significant rib length and if a part of the sternum had also been resected (Figure 2).
The patient"s comorbid conditions and demographics, the location of the lesion, the number of ribs removed, the state of the lung resection, the soft tissue or skin reconstruction, the materials utilized during the operation, 30-day mortality, postoperative complications, reasons and frequency of reoperations, late problems related to reconstruction, and length of stay were all recorded. Complications that developed within 30 days postoperatively or complications such as pneumonia, atelectasis, respiratory failure, and prolonged air leakage (>7 days) that developed due to the reconstruction technique were evaluated. Epidural analgesics, intravenous analgesic infusions, and patient-controlled analgesics were all used to manage postoperative pain.
Table 1. The demographic features of patients
The significant differences between the primary closure and chest wall reconstruction groups are summarized in Table 2. Remarkably, patients in the chest wall reconstruction group had considerably greater deficiencies than in the primary closure group (37.5 cm2 vs. 2 0 c m2, p=0.009). In comparison to the primary closure group, more ribs were removed in the chest wall reconstruction group (p=0.001). There were no significant differences between the groups in malignant pathologies or the number of concomitant lung resections (p=0.532 and p=0.245). Concomitant lung resections were performed in 13 of the 33 malignant patients.
Table 2. The operative variables of the two groups
The complication rates were not different between the two groups (p=0.426). There was no postoperative respiratory failure in any patient. In the first 30 days, one patient suffered chylothorax, three patients developed postoperative pneumonia, and two patients acquired a wound infection. There was no 30-day mortality in any group.
The mean duration of postoperative follow-up was not different between the two groups (primary closure group, 659.7±431.5 days vs. chest wall reconstruction group, 606.4±344.3 days; p=0.589). In terms of long-term complications, seven patients required reoperation. As a result of a fistulized infection in the skin, two patients in the primary closure group underwent reoperation. In the chest wall reconstruction group, three patients had reoperation for recurrences, one patient for bronchopulmonary fistula, and one patient for osteomyelitis. No lung herniation was observed in any patient during follow-up.
Further analysis of the patients in the chest wall reconstruction group focused on their method of reconstruction, namely plaque implantation alone and plaque implantation combined with mesh with or without muscle flap repair. In terms of patient demographics, there was no statistically significant difference between the two groups (Table 3). No significant differences were found for the operative variables.
A prosthetic material should be sufficiently rigid, compatible with the rib cage's concavity, chemically and physically inert, allow for tissue growth, be radiolucent, infection-resistant, and cost-effective. The lack of quality prospective research limits an assessment of the literature on clinical outcomes after chest wall excision and prosthetic reconstruction. Consequently, a few small case studies and anecdotal surgeon experience guide current practice.[4,6,8,9] Weyant et al.[7] found no difference in overall complication rates in their study of 262 patients with a rigid prosthesis (Marlex methyl methacrylate sandwich), a nonrigid prosthesis (polypropylene or PTFE), or no prosthesis. Notably, wound complications such as seroma, hematoma, and infection were slightly higher in the methyl methacrylate group compared to the patch group. We may probably conclude that prosthetic chest wall reconstruction can preserve preoperative pulmonary function based on the literature that is currently available.[9,10] This is supported by our study's finding that patients using prosthetic material experienced similar complication rates to those of primary closure patients.
Thoracic surgeons are familiar with the importance of maintaining chest wall dynamics with skeletal stabilization and clinical improvement in multiple rib fractures and flail chest after trauma. The wide range of fractures observed in flail chest injuries can be accommodated by titanium plate implant systems, which also offer dependable fixation.[11] The titanium plate's shape is user-friendly and ergonomic, which can lessen the likelihood of a prosthesis fracture.[12,13] Better chest wall reconstruction is made possible by the titanium plate, which imitates natural anatomy and physiology to address greater deficiencies and lower the risk of respiratory failure.[13]
The improvements comprise more accurate preoperative localization of rib fractures utilizing ultrasonography or three-dimensional computed tomography reconstruction technologies, as well as more reliable rib fixation using specifically created plating systems.[14] Selective metal laser sintering three-dimensional prototyping technology has yielded encouraging results for surgeons who want to increase the adaption of the reconstruction material to respiratory mechanics and generate the material that is closest to the original. A three-dimensional model of the bones can be extracted from computed tomography images using this technology to help the surgeon understand the defect that would appear after resection and construct a patient-specific prosthesis.[15] Thus, a prosthesis that is an exact duplicate of the original can be used to rectify the malformation. However, there is now a restricted supply of this technology, which calls for certain pieces of equipment and skills. Furthermore, the production of 3D implants takes longer and costs more than with conventional techniques. Moreover, stabilizing this kind of material during the repair of a significant defect is challenging.
Achieving skeletal stabilization is the primary objective of rebuilding the defect following chest wall excision.[4,13,14] A primary closure can be used to successfully restore the chest wall if the skeletal stability is intact. Autologous muscles are used for primary closure, such as the pectoralis major, rectus abdominus, latissimus dorsi, and external oblique or trapezius muscles.[4]
Larger resections are likely to necessitate sophisticated reconstruction. However, while the number of resected ribs differed between patients who underwent primary closure and those who underwent complex reconstruction in this study, the defect size did not differ significantly. In several prior articles, the number of resected ribs was utilized as a marker to emphasize the defect width. We compared the size of the defect in terms of mathematical area, which we believe will provide more reliable information. In this respect, we suggest that the size of the defect or the number of ribs removed should not be used as a stand-alone indication for the need for complex reconstruction requiring additional material. In our opinion, the location of the defect is the most significant factor. We believe that the most important determining factor in reconstruction is the localization of the defect.
Both the primary closure group and the chest wall reconstruction group included patients who underwent malignancy-related resections and concomitant lung resections. However, the complication rate and length of hospitalization were not different. In malignant patients in whom a clean surgical margin is targeted, the defect may be closed with less sophisticated methods depending on its localization and size. However, we did not find evidence that complex reconstruction increases the complication rate.
The median hospital stay and complications were not different between the patients who underwent plate implantation alone and those in whom plate and mesh were used together. Moreover, the median defect diameter closed in these patients was similar. Therefore, it can be argued that reconstructions characterized by the use of multiple materials do not make patients more vulnerable to complications.
Wong et al.[13] reported no in-hospital or early postoperative mortality in their 10-year experience with long-term outcomes after chest wall reconstructions with titanium plates. They emphasized that titanium plates provide a safe and effective reconstruction, and long-term complications are rare and manageable.
In-hospital mortality was reported to be more than 7% in earlier studies.[4] However, we did not observe any in-hospital mortality in our study. We did not observe any prosthetic breakage, screw loosening, or plate malrotation. This can be explained both by improved perioperative management due to surgical techniques, including the use of steel wire to stabilize the plate in critical areas, improvements in material quality, and the fact that all patients were adults. The pediatric patient group, in which growth continues, is more sensitive to complications related to the growth-limiting effect of titanium plates. The data on chest wall reconstruction in pediatric patients is insufficient, and precisely how best to treat these patients is still under debate.
Our length of hospitalization is consistent with the median length of hospitalization of 7 days in previous series.[4,6,13] This is contrary to the approach that suggests that with each foreign material to be used in complex reconstruction, recovery is prolonged and complications increase. Although we suggest that clinicians should keep in mind that less is better and no approach is the best, we believe that one should not avoid using prosthetic material when necessary.
There are a number of limitations to this study. First, owing to the study's retrospective design, patients' needs for reconstruction varied widely. In addition, the study is exploratory in nature and has a limited sample size. Second, the surgeon's experience has a role in determining the sort of surgery and reconstruction that is chosen. Furthermore, as primary repair generally fails to provide adequate support for tissue defects, attaining negative margins in malignant lesions is likely to result in bigger chest wall deficiencies and necessitate more intricate reconstructions. A comprehensive follow-up of the potential benefits of reconstruction was not possible due to the lack of documentation of patients' individual clinical details.
In conclusion, this study created a baseline for comparing clinical outcomes, particularly long-term postoperative issues with the use of a plate or mesh, with or without a muscle flap, in complex reconstructions. It might be quite challanging to reconstruct extensive chest wall defects after chest wall excision. Increasing the quality of life of patients and decreasing mortality after chest wall resection is closely related to preventing early and late complications in patients. As a result, future prospective studies that incorporate assessments of quality of life and lung function employing various reconstruction techniques are necessary.
Ethics Committee Approval: The study protocol was approved by the Gülhane Training and Research Hospital Ethics Committee (date: 14.02.2023, no: 2023-60). The study was conducted in accordance with the principles of the Declaration of Helsinki.
Patient Consent for Publication: A written informed consent was obtained from the patients and/or parents of the patients.
Data Sharing Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.
Author Contributions: Idea/concept: M.S.I., K.K., H.I.; Design: H.I., K.K.; Control/supervision: K.K., H.C..; Data collection and/or processing: M.Y, U.U., D.K.; Analysis and/or interpretation: M.S.I., E.S., H.I.; Literature review: M.S.I., H.I., E.S.; Writing the article: M.S.I., K.K., H.I.; Critical review: H.C.
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Funding: The authors received no financial support for the research and/or authorship of this article.
1) Ferraro P, Cugno S, Liberman M, Danino MA, Harris
PG. Principles of chest wall resection and reconstruction.
Thorac Surg Clin 2010;20:465-73. doi: 10.1016/j.
thorsurg.2010.07.008.
2) Isaac KV, Elzinga K, Buchel EW. The best of chest wall
reconstruction: Principles and clinical application for
complex oncologic and sternal defects. Plast Reconstr Surg
2022;149:547e-62e. doi: 10.1097/PRS.0000000000008882.
3) Wang L, Yan X, Zhao J, Chen C, Chen C, Chen J, et al.
Expert consensus on resection of chest wall tumors and chest
wall reconstruction. Transl Lung Cancer Res 2021;10:4057-83. doi: 10.21037/tlcr-21-935.
4) Mansour KA, Thourani VH, Losken A, Reeves JG,
Miller JI Jr, Carlson GW, et al. Chest wall resections and
reconstruction: A 25-year experience. Ann Thorac Surg
2002;73:1720-6. doi: 10.1016/s0003-4975(02)03527-0.
5) Duranti L, Tavecchio L. New perspectives in prosthetic
reconstruction in chest wall resection. Updates Surg
2023;75:1093-102. doi: 10.1007/s13304-023-01562-z.
6) Deschamps C, Tirnaksiz BM, Darbandi R, Trastek VF,
Allen MS, Miller DL, et al. Early and long-term results of
prosthetic chest wall reconstruction. J Thorac Cardiovasc
Surg 1999;117:588-92. doi: 10.1016/s0022-5223(99)70339-9.
7) Weyant MJ, Bains MS, Venkatraman E, Downey RJ, Park
BJ, Flores RM, et al. Results of chest wall resection and
reconstruction with and without rigid prosthesis. Ann Thorac
Surg 2006;81:279-85. doi: 10.1016/j.athoracsur.2005.07.001.
8) Lardinois D, Müller M, Furrer M, Banic A, Gugger M,
Krueger T, et al. Functional assessment of chest wall integrity
after methylmethacrylate reconstruction. Ann Thorac Surg
2000;69:919-23. doi: 10.1016/s0003-4975(99)01422-8.
9) Daigeler A, Druecke D, Hakimi M, Duchna HW, Goertz
O, Homann HH, et al. Reconstruction of the thoracic walllong-
term follow-up including pulmonary function tests.
Langenbecks Arch Surg 2009;394:705-15. doi: 10.1007/
s00423-008-0400-9.
10) Hanna WC, Ferri LE, McKendy KM, Turcotte R, Sirois C,
Mulder DS. Reconstruction after major chest wall resection:
Can rigid fixation be avoided? Surgery 2011;150:590-7. doi:10.1016/j.surg.2011.07.055.
11) Bottlang M, Long WB, Phelan D, Fielder D, Madey SM.
Surgical stabilization of flail chest injuries with MatrixRIB
implants: A prospective observational study. Injury
2013;44:232-8. doi: 10.1016/j.injury.2012.08.011.
12) Ng CS, Ho AM, Lau RW, Wong RH. Chest wall reconstruction
with MatrixRib system: Avoiding pitfalls. Interact Cardiovasc
Thorac Surg 2014;18:402-3. doi: 10.1093/icvts/ivt515.
13) Wong THY, Siu ICH, Lo KKN, Tsang EYH, Wan IYP, Lau
RWH, et al. Ten-year experience of chest wall reconstruction:
Retrospective review of a titanium plate MatrixRIB? system.
Front Surg 2022;9:947193. doi: 10.3389/fsurg.2022.947193.